Fusion Pharmaceuticals Inc. Operating Lease Liability
Fusion Pharmaceuticals Inc. had Operating Lease Liability of $14.86 million as of 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2024-05-07
- 2024-03-31: Operating Lease, Liability $14.86M.
- 2023-12-31: Operating Lease, Liability $15.56M.
- 2023-09-30: Operating Lease, Liability $18.00M.
- 2023-06-30: Operating Lease, Liability $16.13M.
| Period end | Operating Lease, Liability | Operating Lease, Liability as first filed |
|---|---|---|
| 2024-03-31 | $14.86M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $15.56M 10-K · filed 2024-03-20 | |
| 2023-09-30 | $18.00M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $16.13M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $15.71M 10-Q · filed 2023-05-11 | |
| 2023-02-28 | $1.50M 10-Q · filed 2023-08-08 | |
| 2022-12-31 | $6.02M 10-K · filed 2023-03-16 | |
| 2022-09-30 | $6.30M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $6.66M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $6.99M 10-Q · filed 2022-05-10 | |
| 2022-01-12 | $300.00K 10-Q · filed 2024-05-07 | |
| 2021-12-31 | $6.72M 10-K · filed 2022-03-17 | |
| 2021-09-30 | $7.11M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $7.34M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $1.20M 10-Q · filed 2024-05-07 | $7.52M 10-Q · filed 2021-05-11 |
| 2021-03-16 | $1.20M 10-K · filed 2024-03-20 |